These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6251399

  • 1. Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors.
    Neuwelt EA, Frenkel EP, Diehl J, Vu LH, Rapoport S, Hill S.
    Neurosurgery; 1980 Jul; 7(1):44-52. PubMed ID: 6251399
    [Abstract] [Full Text] [Related]

  • 2. Intra-arterial ACNU chemotherapy employing 20% mannitol osmotic blood-brain barrier disruption for malignant brain tumors.
    Miyagami M, Tsubokawa T, Tazoe M, Kagawa Y.
    Neurol Med Chir (Tokyo); 1990 Aug; 30(8):582-90. PubMed ID: 1703636
    [Abstract] [Full Text] [Related]

  • 3. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
    Siegal T, Rubinstein R, Bokstein F, Schwartz A, Lossos A, Shalom E, Chisin R, Gomori JM.
    J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648
    [Abstract] [Full Text] [Related]

  • 4. Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption.
    Neuwelt EA, Diehl JT, Vu LH, Hill SA, Michael AJ, Frenkel EP.
    Ann Intern Med; 1981 Apr; 94(4 pt 1):449-54. PubMed ID: 6782926
    [Abstract] [Full Text] [Related]

  • 5. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
    Williams PC, Henner WD, Roman-Goldstein S, Dahlborg SA, Brummett RE, Tableman M, Dana BW, Neuwelt EA.
    Neurosurgery; 1995 Jul; 37(1):17-27; discussion 27-8. PubMed ID: 8587686
    [Abstract] [Full Text] [Related]

  • 6. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
    Neuwelt EA, Hill SA, Frenkel EP, Diehl JT, Maravilla KR, Vu LH, Clark WK, Rapoport SI, Barnett PA, Lewis SE, Ehle AL, Beyer CW.
    Cancer Treat Rep; 1981 Jul; 65 Suppl 2():39-43. PubMed ID: 6809316
    [Abstract] [Full Text] [Related]

  • 7. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
    Fortin D, Desjardins A, Benko A, Niyonsega T, Boudrias M.
    Cancer; 2005 Jun 15; 103(12):2606-15. PubMed ID: 15880378
    [Abstract] [Full Text] [Related]

  • 8. [Blood-brain barrier opening microcirculation in human brain tumor].
    Sato S, Toya S, Otani M.
    No To Shinkei; 1985 Feb 15; 37(2):109-13. PubMed ID: 2988587
    [Abstract] [Full Text] [Related]

  • 9. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.
    Neuwelt EA, Rapoport SI.
    Fed Proc; 1984 Feb 15; 43(2):214-9. PubMed ID: 6692941
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery.
    Neuwelt EA, Maravilla KR, Frenkel EP, Rapaport SI, Hill SA, Barnett PA.
    J Clin Invest; 1979 Aug 15; 64(2):684-8. PubMed ID: 457877
    [Abstract] [Full Text] [Related]

  • 15. Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning.
    Neuwelt EA, Specht HD, Howieson J, Haines JE, Bennett MJ, Hill SA, Frenkel EP.
    AJR Am J Roentgenol; 1983 Oct 15; 141(4):829-35. PubMed ID: 6412531
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.
    Neuwelt EA, Howieson J, Frenkel EP, Specht HD, Weigel R, Buchan CG, Hill SA.
    Neurosurgery; 1986 Oct 15; 19(4):573-82. PubMed ID: 3097567
    [Abstract] [Full Text] [Related]

  • 18. Lack of correlation between clinical and angiographic findings in patients with brain tumors under BCNU chemotherapy.
    Koo AH, Fewer D, Wilson CB, Newton TH.
    J Neurosurg; 1972 Jul 15; 37(1):9-14. PubMed ID: 4338690
    [No Abstract] [Full Text] [Related]

  • 19. Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review.
    Gumerlock MK, Belshe BD, Madsen R, Watts C.
    J Neurooncol; 1992 Jan 15; 12(1):33-46. PubMed ID: 1541977
    [Abstract] [Full Text] [Related]

  • 20. Osmotic blood-brain barrier disruption in the posterior fossa of the dog.
    Neuwelt EA, Glasberg M, Diehl J, Frenkel EP, Barnett P.
    J Neurosurg; 1981 Nov 15; 55(5):742-8. PubMed ID: 6796658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.